KR890015745A - 수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법 - Google Patents

수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법 Download PDF

Info

Publication number
KR890015745A
KR890015745A KR1019890004209A KR890004209A KR890015745A KR 890015745 A KR890015745 A KR 890015745A KR 1019890004209 A KR1019890004209 A KR 1019890004209A KR 890004209 A KR890004209 A KR 890004209A KR 890015745 A KR890015745 A KR 890015745A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
aqueous solution
active ingredient
present
pyricampum
Prior art date
Application number
KR1019890004209A
Other languages
English (en)
Inventor
키에시 파올로
파베시 루시아나
Original Assignee
원본미기재
키에시 파르마세우티시 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 키에시 파르마세우티시 에스.피.에이. filed Critical 원본미기재
Publication of KR890015745A publication Critical patent/KR890015745A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

내용 없음

Description

수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 수용액으로 존재하는 피록시캄의 주사용 또는 눈투여용 제약 조성물.
  2. 제 1 항에 있어서, 즉시 사용가능한 용액 형태 또는 사용 직전 주사용수에 용해시키는 동결건조 형태로 투여량 단위 당 유효 성분 10 내지 30mg을 함유하는 주사용 제약 조성물.
  3. 제 1 항에 있어서, 유효 성분의 농도가 0.2 내지 1%인 눈 투여용 제약 조성물.
  4. (a) 유효 성분을 물 중에 1 내지 4%(중량/용적)의 농도로 분산시키고, (b) 화학량론적 양의 알칼리 금속 또는 알칼리토금속의 수산화물 수용액을 완전 용해되도록 교반하면서 상기 수용액에 첨가하고, (c) pH 안정화제로서 글리코콜을 8 내지 10%(중량/용적) 범위의 양으로 수용액에 첨가하는 것을 특징으로 하는, 제1 내지 3항중 어느 하나의 항에 의해 제약 조성물의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890004209A 1988-04-01 1989-03-31 수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법 KR890015745A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20073A/88 1988-04-01
IT8820073A IT1216686B (it) 1988-04-01 1988-04-01 Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.

Publications (1)

Publication Number Publication Date
KR890015745A true KR890015745A (ko) 1989-11-25

Family

ID=11163585

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890004209A KR890015745A (ko) 1988-04-01 1989-03-31 수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법

Country Status (19)

Country Link
US (1) US4942167A (ko)
EP (1) EP0336200B1 (ko)
JP (1) JPH01299230A (ko)
KR (1) KR890015745A (ko)
AT (1) ATE85757T1 (ko)
AU (1) AU608142B2 (ko)
CA (1) CA1321352C (ko)
DE (2) DE68904922T2 (ko)
DK (1) DK157689A (ko)
ES (1) ES2011232T3 (ko)
FI (1) FI90202C (ko)
GR (2) GR890300196T1 (ko)
IE (1) IE63714B1 (ko)
IT (1) IT1216686B (ko)
MA (1) MA21527A1 (ko)
NO (1) NO175406C (ko)
NZ (1) NZ228576A (ko)
PT (1) PT90124B (ko)
ZA (1) ZA892399B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241088B (it) * 1990-03-27 1993-12-29 Chiesi Farma Spa Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
US5420124A (en) * 1994-01-12 1995-05-30 Kim; Young S. Stable, painless piroxicam potassium injectable composition
CN1047077C (zh) * 1994-01-15 1999-12-08 金元圭 稳定、无痛的吡罗昔康钾可注射组合物
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
DK0909562T3 (da) * 1996-07-03 2005-08-22 Eisai Co Ltd Injektionspræparat indeholdende en lipid A analog og fremgangsmåde til fremstilling deraf
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
JP4674162B2 (ja) * 2003-11-14 2011-04-20 千寿製薬株式会社 アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2007039417A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CA3132227A1 (en) * 2019-03-01 2020-09-10 Eurofarma Laboratorios S.A. Non-steroid anti-inflammatory pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE421792B (sv) * 1976-01-12 1982-02-01 Pfizer Forfarande for framstellning av n-(2-pyridyl)-4-hydroxi-2-metyl-2h-1,2-benso-tiazin-3-karboxamid-1,1-dioxid

Also Published As

Publication number Publication date
FI90202C (fi) 1994-01-10
CA1321352C (en) 1993-08-17
MA21527A1 (fr) 1989-10-01
NO891367D0 (no) 1989-03-31
GR3007107T3 (ko) 1993-07-30
IE891032L (en) 1989-10-01
EP0336200A1 (en) 1989-10-11
NO175406B (no) 1994-07-04
ES2011232A4 (es) 1990-01-01
FI891570A (fi) 1989-10-02
DK157689D0 (da) 1989-03-31
DK157689A (da) 1989-10-02
NO175406C (no) 1994-10-12
DE68904922D1 (de) 1993-03-25
NO891367L (no) 1989-10-02
IE63714B1 (en) 1995-05-31
DE68904922T2 (de) 1993-06-03
AU3229789A (en) 1989-10-05
NZ228576A (en) 1990-10-26
EP0336200B1 (en) 1993-02-17
IT1216686B (it) 1990-03-08
ES2011232T3 (es) 1994-01-16
ATE85757T1 (de) 1993-03-15
AU608142B2 (en) 1991-03-21
PT90124B (pt) 1994-06-30
DE336200T1 (de) 1990-03-01
ZA892399B (en) 1989-11-29
PT90124A (pt) 1989-11-10
US4942167A (en) 1990-07-17
FI90202B (fi) 1993-09-30
JPH01299230A (ja) 1989-12-04
GR890300196T1 (en) 1990-11-29
IT8820073A0 (it) 1988-04-01
FI891570A0 (fi) 1989-03-31

Similar Documents

Publication Publication Date Title
KR890015745A (ko) 수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법
KR900013952A (ko) 경구투여용 이부프로펜 조성물
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
KR890011590A (ko) 안지오스타틴
KR900015737A (ko) 배합물
KR880004819A (ko) 펩티드 제제
KR880003616A (ko) 상처치료제
US2442461A (en) Stable solutions of calcium ascorbate
KR890012634A (ko) 제약 조성물의 안정성을 개선시키는 방법
KR900013964A (ko) 활성형 비타민 d₃류 제제용 조성물 및 이를 함유하는 안정한 활성형 비타민 d₃류 제제의 제조방법
US6121250A (en) Lavage solution for intestinal tract
ES2064622T3 (es) Disolucion acuosa concentrada de glutaraldehido y 1,2-benzisotiazolin-3-ona.
KR840004347A (ko) 불안정한 약물 또는 음식물 첨가물의 안정화
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
KR910007509A (ko) 친유성 약제용 주사 조성물
GB1072355A (en) Antiseptic and anti-pruretic solution containing camphor
KR880002507A (ko) 페닐퀴놀린 카복실산의 동결건조 약제 조성물
KR890012960A (ko) 결정성 β-락탐 용매화물
US2667440A (en) Stabilized aqueous solutions of paraminosalicylic acid salts
US2874089A (en) Stable vitamin b12 solutions
KR950000149A (ko) 오메프라졸 주사용 제제
ATE386512T1 (de) Vorgemischte amiodaron-haltige parenterale lösung und deren herstellungsverfahren
KR900013959A (ko) γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
JPS56139414A (en) Stabilizing method of aqueous solution
KR890011594A (ko) 4-아로일이미다졸-2-온의 제약 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee